)
Drug to cure mild to moderate symptoms of COVID-19: 'Favipiravir' or 'Fabiflu'
Favipiravir and anti-viral medication developed in Japan is currently the subject of 18 trials around the world as a potential treatment for COVID-19. Watch report.
Favipiravir and anti-viral medication developed in Japan is currently the subject of 18 trials around the world as a potential treatment for COVID-19. Watch report.
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)